Trevi Therapeutics, Inc. (TRVI) Interest Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Trevi Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2024.
  • Trevi Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $1 K, a 99.6% decline year-over-year.
  • Trevi Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $161 K, a 85.3% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Interest Expense for 2023 was $391 K, a 66.4% decline from 2022.
  • Trevi Therapeutics, Inc. annual Interest Expense for 2022 was $1.16 M, a 3.25% decline from 2021.
  • Trevi Therapeutics, Inc. annual Interest Expense for 2021 was $1.2 M, a 164% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $161 K $1 K -$230 K -99.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $391 K $4 K -$270 K -98.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $661 K $3 K -$289 K -99% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $950 K $153 K -$142 K -48.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.09 M $231 K -$71 K -23.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.16 M $274 K -$35 K -11.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $1.2 M $292 K -$11 K -3.63% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.21 M $295 K -$1 K -0.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.21 M $302 K +$8 K +2.72% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.2 M $309 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $303 K +$155 K +105% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $296 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $294 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $148 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2018 $51 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $123 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.